Lactobacillus reuteri UALre-16 and Reduced Crying Time in Infants with Colic

• Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial.

  • 2013-02
  • RCT · n = 80
  • The Journal of Pediatrics 162(2)
  • • H. Szajewska
    • E. Gyrczuk
    • A. Horváth

  • PubMed: 22981952
  • DOI: 10.1016/j.jpeds.2012.08.004

  6 Insights on

  • Reduced Crying Time in Infants with Colic

  • High evidence
  • Highly Cited

  The primary outcome measures were the treatment success, defined as the percentage of children achieving a reduction in the daily average crying time ≥ 50%, and the duration of crying (minutes per day) at 7, 14, 21, and 28 days after randomization.

  Effect

  Beneficial

  Effect size

  Large

  Significant

  Yes